- Home
- SDOT vs ACXP Comparison
SDOT vs ACXP Comparison
Compare SDOT & ACXP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SDOT
- ACXP
- Stock Information
- Founded
- SDOT 2014
- ACXP 2017
- Country
- SDOT United States
- ACXP United States
- Employees
- SDOT N/A
- ACXP N/A
- Industry
- SDOT Restaurants
- ACXP Biotechnology: Pharmaceutical Preparations
- Sector
- SDOT Consumer Discretionary
- ACXP Health Care
- Exchange
- SDOT Nasdaq
- ACXP Nasdaq
- Market Cap
- SDOT 8.0M
- ACXP 8.4M
- IPO Year
- SDOT 2020
- ACXP 2021
- Fundamental
- Price
- SDOT $1.41
- ACXP $0.43
- Analyst Decision
- SDOT
- ACXP Strong Buy
- Analyst Count
- SDOT 0
- ACXP 2
- Target Price
- SDOT N/A
- ACXP $10.00
- AVG Volume (30 Days)
- SDOT 566.5K
- ACXP 18.4M
- Earning Date
- SDOT 08-12-2025
- ACXP 08-08-2025
- Dividend Yield
- SDOT N/A
- ACXP N/A
- EPS Growth
- SDOT N/A
- ACXP N/A
- EPS
- SDOT 1.07
- ACXP N/A
- Revenue
- SDOT $726,598,000.00
- ACXP N/A
- Revenue This Year
- SDOT $12.76
- ACXP N/A
- Revenue Next Year
- SDOT $5.54
- ACXP N/A
- P/E Ratio
- SDOT $1.30
- ACXP N/A
- Revenue Growth
- SDOT 18.91
- ACXP N/A
- 52 Week Low
- SDOT $1.12
- ACXP $0.30
- 52 Week High
- SDOT $7.00
- ACXP $3.33
- Technical
- Relative Strength Index (RSI)
- SDOT 53.10
- ACXP 47.99
- Support Level
- SDOT $1.33
- ACXP $0.52
- Resistance Level
- SDOT $1.24
- ACXP $0.63
- Average True Range (ATR)
- SDOT 0.21
- ACXP 0.09
- MACD
- SDOT 0.02
- ACXP 0.00
- Stochastic Oscillator
- SDOT 41.76
- ACXP 17.33
About SDOT Sadot Group Inc.
Sadot Group Inc operates in the food supply chain sector, connecting producers and consumers across the globe, delivering agri-commodities from producing geographies such as the Americas, Africa, and the Black Sea to consumer markets in Southeast Asia, China and the Middle East/North Africa (MENA) region. Its reportable segment includes Sadot food service and Sadot agri-foods. The key revenue is coming from the Sadot agri-foods segment which engaged in farming, commodity trading, and shipping of food and feed.
About ACXP Acurx Pharmaceuticals Inc.
Acurx Pharmaceuticals Inc is a clinical stage biopharmaceutical company developing a new class of antibiotics for infections caused by bacteria listed as priority pathogens by the World Health Organization, Centers for Disease Control and Prevention and Food and Drug Administration. The company's approach is to develop antibiotic candidates with a Gram-positive selective spectrum. The Company's segment consists of the development of clinical and preclinical product candidates for the development of the Company's proprietary new therapies.